*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Ibudilastand Octreotide both Ameliorate Acute Pancreatitis via Down-Regulation of the Inflammatory Cytokines and Toll-Like Receptor 4 Expression

Author: ALAA GHAZI, SAMEER H ABOOD, HASSAN ALAKOULI, FATIMA GHIZAL, ABDI AFROZ, NAJAH HADI
Abstract: Acute pancreatitis (AP) is severe inflammationof the pancreas that can be of two major types: mild AP (MAP) and severe AP (SAP).To study the therapeutic effect of Ibudilast in comparison with older drug, Octreotide, in the rat model of AP.A total of 48 male rats were divided into 8groupswith each group consisting of 6 rats. Acute Pancreatitis was induced by L-arginine model which has a high reproducibility. Octreotide and Ibudilast were administered individually and in combinationat 0, 8 and 16 hours after induction. After 24 hours of treatment, each rat was weighed and blood samples were withdrawn for ELISA test and for Toll-like receptor 4 (TLR4) expressionanalysis, and then the pancreas was extractedto obtainthe pancreatic weight to the totalbody weight(PW/TBW) ratio.
Keyword: Ibudilast, Octreotide, Acute Pancreatitis, Inflammatory Cytokines, Toll-Like Receptor
DOI: https://doi.org/10.31838/ijpr/2019.11.02.024
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free